Ex Parte Eckel et al - Page 9

               Appeal 2007-4316                                                                            
               Application 09/911,268                                                                      
               particular chemical structure for an oligophosphate in the Eckel 930 and                    
               Gaggar specifications indicate that IPP is present as an impurity at less than              
               1 w%, as required by Applicants' claims.  (Answer at 4 and 5.)  Because                     
               Applicants have not made any arguments regarding the separate patentability                 
               of any of the claims, we need not address the claims separately.  Moreover,                 
               arguments not made in the principal appeal brief have been waived.                          
               37 C.F.R. § 41.37(c)(1)(vii).                                                               
                      The Examiner has not offered any other explanation of why it appears                 
               that Eckel 930 and Gaggar describe compositions that are the same or                        
               substantially the same as the presently claimed subject matter.  In particular,             
               the Examiner has not directed our attention to any disclosure in either                     
               Eckel 930 or in Gaggar regarding the synthesis of oligophosphates or their                  
               purification prior to use as a flame retardant.  Nor has the Examiner directed              
               our attention to any properties of the oligophosphate or the polycarbonate                  
               blends that might provide reason to presume that the prior art compositions                 
               describe or reasonably would have suggested Applicants' claimed subject                     
               matter.  Thus, we conclude that the Examiner's theory of the case must be                   
               based on inherency.                                                                         
                      Anticipation by inherency, however, is proven only if the allegedly                  
               inherent property is inevitably present in the prior art.  Applicants argue (Br.            
               at 5), that Dr. Eckel's declaration shows that commercially available                       
               bisphenol A diphenylphosphate, which is said to be the common name for                      
               the compound of formula (V) of the 268 Application, can contain as much as                  
               15 w% IPP.  (Br., Evidence App'x. at 4.)  Accordingly, it is not inevitable                 
               that compound D.1 contained less than 1 w% IPP.  The presence of IPP in                     
               commercially available oligophosphates within the scope of Applicants'                      

                                                   9                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next

Last modified: September 9, 2013